Edition:
United Kingdom

Healthcare Headlines

Merck, Pfizer drug combo extends kidney cancer survival -study

A combination of Merck & Co's immunotherapy Keytruda and Pfizer Inc's Inlyta helped patients with advanced kidney cancer live longer than those receiving and older Pfizer standalone therapy, according to data from a late-stage study presented on Saturday.

Business Video

Top News

UK businesses plan to raise pay by most since 2012 - CIPD

British businesses plan to raise basic wages by the most in at least seven years, due to recruitment difficulties and a need to keep pay in line with competitors, a survey showed on Monday, highlighting ongoing strength in Britain's jobs market.